Some of the most common ones include: Liraglutide (Saxenda, Victoza): Originally approved for type 2 diabetes, liraglutide has shown significant weight loss benefits and is marketed as Saxenda for obesity treatment
Research has established an abnormal HO-1 expression among diabetic individuals, especially in those with complications like cardiovascular disease, neuropathy, nephropathy and diabetic foot ulcers [17, 18]
This side effect is very common and even the skilled injectors or clinic could not completely prevent it from happening
With antibiotic resistance on the rise and chronic infections difficult to treat, researchers are studying what our bodies are already armed with, and LL-37 is proving to be much more intriguing than we ever realized
Genetically modified THP-1 are frequently utilised in the study of specific metabolic pathways, such as the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome, whose assembly plays a central role in the innate immune response to nanoparticles [126]
